EP08.02-104 Osimertinib in Untreated EGFR-Mutant Non-small Cell Lung Cancers: Overall Survival and Budget Impact Analysis in Real-World
Autor: | Lorenzi, M., Scattolin, D., Del Conte, A., Sangiorgi, S., Polo, V., Pavan, A., Pilotto, S., Santarpia, M., Da Ros, V., Maso, A. Dal, Ferro, A., Frega, S., Bortolami, A., Bonanno, L., Indraccolo, S., Guarneri, V., Pasello, G. |
---|---|
Zdroj: | In Journal of Thoracic Oncology September 2022 17(9) Supplement:S450-S451 |
Databáze: | ScienceDirect |
Externí odkaz: |